NLR, ELR and SII Index as Biomarkers of Asthma Control

This is Case control study aims to study Neutrophil-to-Lymphocyte Ratio (NLR), Eosinophil-to-Lymphocyte Ratio (ELR), and Systemic Immune Inflammation (SII) Index as Biomarkers of Asthma Controlin adult patients with bronchial asthma. This study will investigate the association between these inflammatory indices and the level of asthma control to assess their potential value as simple ,readily available and cost -effective biomarkers in clinical practice.

NCT Number	NCT07730047
Lead Sponsor	Shaimaa Ali Mohammed
Conditions	Asthma Control
Enrollment	140 participants
Start Date	2026-08-01
Primary Completion	2027-01-01 (estimated)
Study Completion	2027-02-01 (estimated)
Updated on ClinicalTrials.gov	2026-07-28